Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

MERCK SHARP & DOHME LLC

Subsidiary ofMERCK & CO., INC.UEI: FCFDA78HKKG2CAGE: 6B2S4

MERCK SHARP & DOHME LLC is a federal contractor, registered under UEI FCFDA78HKKG2 and CAGE code 6B2S4. It has been awarded $28,190,239,000 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Biological Product (except Diagnostic) Manufacturing, and Medicinal and Botanical Manufacturing. Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Other agencies (6 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

FCFDA78HKKG2

CAGE Code

6B2S4

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)
325414Biological Product (except Diagnostic) Manufacturing

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Merck Sharp & Doe LLC specializes in the manufacturing of FDA-regulated pharmaceutical preparations and biological products for federal healthcare programs, with deep expertise in aseptic processing, sterile drug formulation, and supply chain logistics for high-complexity therapeutics. The contracto...

Merck Sharp & Doe LLC specializes in the manufacturing of FDA-regulated pharmaceutical preparations and biological products for federal healthcare programs, with deep expertise in aseptic processing, sterile drug formulation, and supply chain logistics for high-complexity therapeutics. The contractor delivers critical oncology, hematology, and emergency-use medications under strict cGMP standards, ensuring consistent batch integrity, stability testing, and regulatory compliance for life-saving treatments. Their technical capabilities include end-to-end production of small-molecule and biologic agents, cold chain management, and rapid-response manufacturing for time-sensitive government needs, particularly for specialty drugs requiring controlled storage and distribution. The contractor maintains a sustained, high-frequency partnership with the Department of Veterans Affairs, consistently supplying specialty pharmaceuticals including Belzutifan (Welireg) and Winrevair, indicating a trusted role in managing the VA’s specialty drug formulary for rare and complex conditions. They also serve the Department of Health and Human Services with similar therapeutic products, suggesting alignment with public health emergency preparedness and Medicare Part B drug procurement initiatives. Their relationship with the Department of Justice is limited but points to potential involvement in controlled substance logistics or forensic pharmaceutical support. Primary operations center on NAICS 325412 (pharmaceutical preparation manufacturing), with secondary capability in biological product manufacturing (325414) and refrigerated warehousing (493120), positioning them as a vertically integrated supplier for temperature-sensitive therapeutics. Their market focus is on specialty oncology, rare disease, and emergency response pharmaceuticals, serving as a mission-critical vendor for federal agencies requiring assured, compliant drug availability. As a 2L entity headquartered in Rahway, NJ, Merck Sharp & Doe LLC operates as a large-scale, regulated manufacturer without active small business certifications. Their geographic footprint is anchored in New Jersey, with logistics infrastructure supporting nationwide federal distribution, particularly for high-acuity, low-volume therapeutics requiring stringent environmental controls.

Key Performance Metrics

Awards Count

443

All time

Active

5

Currently performing

Completed

437

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with MERCK SHARP & DOHME LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for MERCK SHARP & DOHME LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in MERCK SHARP & DOHME LLC's top NAICS codes and agencies

NAICS: 541330
New
Federal
Army Contracting Command – Red River Army Depot (ACC-RRAD) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911RQ-27-S-C001
The Army Contracting Command – Red River Army Depot (ACC-RRAD) has issued Commercial Solutions Opening (CSO) W911RQ-27-S-C001 to modernize its Organic Industrial Base (OIB). This initiative focuses on Convergent Manufacturing, seeking innovative commercial items, technologies, and services in areas such as digital twins, automation, cyber security, and agile facilities to enhance the Defense Manufacturing Base. The CSO utilizes a streamlined acquisition process authorized by DFARS Subpart 212-70, allowing both traditional and non-traditional defense contractors to compete for FAR Part 12 commercial item contracts. The overall solicitation remains open until September 30, 2027, with a general period of performance for awarded solutions typically not exceeding 12 months. The procurement is executed through specific Areas of Interest (AoIs), which have included requirements for micro trucks, industrial parts washer leasing and maintenance, and fire suppression system repairs for Building 431. The evaluation process is conducted in three phases: an initial solution brief, a presentation or pitch, and a final Commercial Solutions Proposal. Technical evaluations prioritize responsiveness to the AoI, technical merit, and innovation, while price proposals must be determined as fair and reasonable. Awardees must be registered in the System for Award Management (SAM) and possess a Unique Entity ID. Specific project requirements may include strict adherence to military marking standards, environmental liability insurance, and certification by registered professional engineers.
Department Of Defense

POSTED

about 15 hours ago

DEADLINE

in 12 months
View Details
NAICS: 325412
New
Federal
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America
Solicitation # 36E79726R0041
The Department of Veterans Affairs intends to award a firm-fixed requirements-type contract for Sodium Bicarbonate 84mg/mL Injection 50mL vials, with an estimated annual usage of 65,587 bottles. This procurement is restricted to suppliers with products manufactured in the United States in accordance with FAR 6.103-3 and will be issued in a commercial item format per FAR Part 12. The contract will support multiple agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a base period of one year, with four pre-priced one-year option periods. Under NAICS code 325412, the solicitation requires offerors to provide a unique NDC number and the exact drug name as it appears on the label. Strict labeling standards apply: the contractor's unique NDC label must be the only label on the product, and labels cannot be affixed over existing ones; however, they must allow VA labels to adhere securely on top. While glass bottles are acceptable, all packaging must be compatible with automated dispensing units such as Opti-fill and Baxter ATC Canisters. The solicitation is expected to be issued on October 21, 2026, with a tentative closing date of November 18, 2026, and all communications and submissions must be handled electronically via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

4 days ago

DEADLINE

in 1 day
View Details